Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
The Oncologist|February 13, 2020
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK TranslocationSandip Pravin Patel, Suchita Pakkala, Nathan A Pennell, et al.Scientific Reports|August 9, 2020
Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactionsManuela Gago-Dominguez, Marcos Matabuena, Carmen M Redondo, et al.Translational Cancer Research|February 4, 2022
Next generation sequencing of cell free circulating tumor DNA in blood samples of recurrent and metastatic head and neck cancer patientsAshleigh Porter, Mandy Natsuhara, Gregory A Daniels, et al.Scientific Reports|November 21, 2020
Author Correction: Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactionsManuela Gago-Dominguez, Marcos Matabuena, Carmen M Redondo, et al.Scientific Reports|August 31, 2021
Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing dataTigran Makunts, Ila M Saunders, Isaac V Cohen, et al.Proceedings of the National Academy of Sciences of the United States of America|August 5, 2020
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironmentNa Li, Yuqi Kang, Lingling Wang, et al.Journal for Immunotherapy of Cancer|September 27, 2018
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor-related protein agonist AMG 228 in patients with advanced solid tumorsBen Tran, Richard D Carvajal, Aurelien Marabelle, et al.Frontiers in Immunology|May 2, 2022
CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung CancerClaire Olingy, Ahmad Alimadadi, Daniel J Araujo, et al.Case Reports in Oncology|October 30, 2024
A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the LiteratureHelena Ferreira Bruzzi Porto, Gabriela C K Lopes, Hannah B V Bekierman, et al.Cancer Research Communications|October 15, 2025
Molecular Characterization of Oncogenic Gene Fusions in a Large Real-World Cohort of Solid TumorsLisa Gai, Bradley Bowles, Adam J Hockenberry, et al.Pageof 6